CBU
PFE icon

CIBC Bank USA’s Pfizer PFE Stock Holding History

CIBC Bank USA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.48M Buy
66,858
+746
+1% +$26.6K 0.33% 47
2019
Q3 		$2.25M Buy
66,112
+4,636
+8% +$169K 0.32% 46
2019
Q2 		$2.53M Sell
61,476
-169
-0.3% -$6.71K 0.35% 44
2019
Q1 		$2.48M Sell
61,645
-2,314
-4% -$92.7K 0.35% 46
2018
Q4 		$2.65M Buy
63,959
+328
+0.5% +$13.6K 0.43% 35
2018
Q3 		$2.66M Buy
63,631
+3,005
+5% +$116K 0.36% 42
2018
Q2 		$2.09M Sell
60,626
-2,048
-3% -$70K 0.29% 47
2018
Q1 		$2.11M Sell
62,674
-7,635
-11% -$262K 0.29% 48
2017
Q4 		$2.42M Sell
70,309
-1,749
-2% -$59.6K 0.31% 41
2017
Q3 		$2.44M Buy
72,058
+4,471
+7% +$144K 0.32% 40
2017
Q2 		$2.15M Buy
67,587
+504
+0.8% +$15.9K 0.29% 40
2017
Q1 		$2.18M Sell
67,083
-696
-1% -$21.9K 0.3% 38
2016
Q4 		$2.09M Buy
67,779
+416
+0.6% +$12.7K 0.3% 41
2016
Q3 		$2.16M Buy
67,363
+1,337
+2% +$44.7K 0.33% 42
2016
Q2 		$2.21M Buy
66,026
+635
+1% +$20.3K 0.34% 41
2016
Q1 		$1.84M Sell
65,391
-211
-0.3% -$6.03K 0.32% 47
2015
Q4 		$2.01M Buy
65,602
+2,713
+4% +$85.3K 0.35% 47
2015
Q3 		$1.87M Buy
62,889
+184
+0.3% +$5.9K 0.34% 44
2015
Q2 		$2M Sell
62,705
-1,027
-2% -$33.5K 0.33% 46
2015
Q1 		$2.1M Sell
63,732
-688
-1% -$21.9K 0.37% 41
2014
Q4 		$1.9M Sell
64,420
-1,134
-2% -$32.5K 0.33% 48
2014
Q3 		$1.84M Sell
65,554
-8,191
-11% -$230K 0.37% 48
2014
Q2 		$2.08M Buy
73,745
+3,306
+5% +$94.2K 0.39% 43
2014
Q1 		$2.15M Buy
70,439
+8,969
+15% +$267K 0.44% 40
2013
Q4 		$1.79M Sell
61,470
-871
-1% -$25.3K 0.4% 49
2013
Q3 		$1.7M Sell
62,341
-391,818
-86% -$10.7M 0.42% 49
2013
Q2 		$12.1M Buy
+454,159
New +$12.5M 0.71% 34

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CIBC Bank USA's PFE Position: Q4 2019 in Review

CIBC Bank USA increased its Pfizer (PFE) stake by 1.1% in Q4 2019, buying an estimated $26.6K and bringing the position to 66,858 shares worth $2.48M. The position accounts for 0.33% of the portfolio, ranked #47.

CIBC Bank USA first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $12.1M in Q2 2013. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • CIBC Bank USA held 66,858 shares of Pfizer worth $2.48M as of Q4 2019.
  • CIBC Bank USA bought 746 Pfizer shares in Q4 2019, an estimated $26.6K.
  • Pfizer made up 0.33% of CIBC Bank USA's portfolio in Q4 2019, its #47 holding.
  • CIBC Bank USA first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
  • CIBC Bank USA's Pfizer position peaked at $12.1M in Q2 2013.
  • 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.